Alfredo Adán

7.0k total citations
238 papers, 3.6k citations indexed

About

Alfredo Adán is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Alfredo Adán has authored 238 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Ophthalmology, 43 papers in Radiology, Nuclear Medicine and Imaging and 41 papers in Rheumatology. Recurrent topics in Alfredo Adán's work include Ocular Diseases and Behçet’s Syndrome (129 papers), Retinal and Optic Conditions (82 papers) and Retinal Diseases and Treatments (73 papers). Alfredo Adán is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (129 papers), Retinal and Optic Conditions (82 papers) and Retinal Diseases and Treatments (73 papers). Alfredo Adán collaborates with scholars based in Spain, United Kingdom and United States. Alfredo Adán's co-authors include Víctor Llorenç, Marina Mesquida, Blanca Molins, Laura Pelegrín, Gerard Espinosa, Maite Sáinz de la Maza, M.V. Hernández, Ricardo P. Casaroli‐Marano, Andrew D. Dick and Marc Figueras‐Roca and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and IEEE Transactions on Pattern Analysis and Machine Intelligence.

In The Last Decade

Alfredo Adán

222 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfredo Adán Spain 31 2.5k 760 560 402 365 238 3.6k
Graham R. Wallace United Kingdom 33 1.7k 0.7× 852 1.1× 316 0.6× 720 1.8× 360 1.0× 117 3.2k
Phyllis B. Silver United States 38 2.0k 0.8× 1.1k 1.5× 170 0.3× 781 1.9× 199 0.5× 91 4.7k
Moncef Khairallah Tunisia 31 2.3k 0.9× 271 0.4× 459 0.8× 244 0.6× 64 0.2× 191 3.3k
Marc Labétoulle France 34 1.8k 0.7× 800 1.1× 1.3k 2.4× 691 1.7× 96 0.3× 199 6.9k
Eiichi Uchio Japan 30 1.3k 0.5× 147 0.2× 998 1.8× 344 0.9× 24 0.1× 146 2.8k
S. D. Cook United States 31 421 0.2× 306 0.4× 334 0.6× 391 1.0× 138 0.4× 80 2.5k
Jaime Levy Israel 27 1.5k 0.6× 74 0.1× 850 1.5× 422 1.0× 52 0.1× 168 2.7k
Atsuki Fukushima Japan 30 952 0.4× 327 0.4× 565 1.0× 466 1.2× 27 0.1× 183 3.2k
Mathea R. Allansmith United States 39 1.1k 0.4× 525 0.7× 841 1.5× 373 0.9× 54 0.1× 136 4.1k
Henry D. Perry United States 43 2.9k 1.1× 184 0.2× 2.6k 4.7× 282 0.7× 72 0.2× 185 5.4k

Countries citing papers authored by Alfredo Adán

Since Specialization
Citations

This map shows the geographic impact of Alfredo Adán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Adán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Adán more than expected).

Fields of papers citing papers by Alfredo Adán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Adán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Adán. The network helps show where Alfredo Adán may publish in the future.

Co-authorship network of co-authors of Alfredo Adán

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Adán. A scholar is included among the top collaborators of Alfredo Adán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Adán. Alfredo Adán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Güell, José L., et al.. (2024). Comparison of intraocular lens tilt after capsular sutured scleral fixation with capsular segments versus uneventful cataract surgery. European Journal of Ophthalmology. 34(5). 1450–1457.
3.
Casaroli‐Marano, Ricardo P., José Hernández‐Rodríguez, Marc Figueras‐Roca, et al.. (2024). New proposal for a multimodal imaging approach for the subclinical detection of hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus. BMJ Open Ophthalmology. 9(1). e001608–e001608.
4.
Casaroli‐Marano, Ricardo P., José Hernández‐Rodríguez, Alfredo Adán, et al.. (2024). Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(9). 2823–2832. 2 indexed citations
5.
Bernal-Morales, Carolina, et al.. (2023). Predictive Factors and Management of Macular Edema after Retropupillary Iris-Claw Intraocular Lens Implantation in Aphakia: National Multicenter Audit—Report 2. Journal of Clinical Medicine. 12(2). 436–436. 1 indexed citations
6.
7.
García‐Otero, Xurxo, Cristina Mondelo‐García, Noemí Gómez‐Lado, et al.. (2022). PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. International Journal of Pharmaceutics. 627. 122261–122261. 10 indexed citations
8.
Pérez-Fernández, Sílvia, et al.. (2022). Clinical Features and Outcomes of Tubulointerstitial Nephritis and Uveitis Syndrome in Spain and Portugal: The IBERTINU Project. Ocular Immunology and Inflammation. 31(2). 286–291. 7 indexed citations
9.
Hernández‐Rodríguez, José, Laura Pelegrín, Michael V. Boland, et al.. (2022). Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre. Lupus. 31(11). 1344–1354. 8 indexed citations
10.
Cunningham, Emmett T., Alfredo Adán, Quan Dong Nguyen, & Manfred Zierhut. (2021). Tocilizumab for the Treatment of Ocular Inflammatory Disease. Ocular Immunology and Inflammation. 29(1). 2–5. 10 indexed citations
11.
Sala‐Puigdollers, Anna, et al.. (2019). Multimodal retinal imaging of familial amyloid polyneuropathy. Ophthalmic Genetics. 40(5). 407–420. 10 indexed citations
12.
Hernández, Teresa, et al.. (2018). Cardiovascular risk factors impact in perifoveal flow in Type 1 Diabetes Mellitus (T1DM) assessed by OCT Angiography (OCTA). Investigative Ophthalmology & Visual Science. 59(9). 1907–1907. 1 indexed citations
13.
Palmou‐Fontana, Natalia, V. Calvo-Río, J. L. Martín-Varillas, et al.. (2018). Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.. PubMed. 36(4). 652–657. 26 indexed citations
14.
Mesquida, Marina, Blanca Molins, Víctor Llorenç, et al.. (2017). TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Retina. 38(7). 1361–1370. 55 indexed citations
15.
Zarranz‐Ventura, Javier, Pearse A. Keane, Dawn A. Sim, et al.. (2015). Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy. American Journal of Ophthalmology. 161. 172–180.e4. 25 indexed citations
16.
Maza, Maite Sáinz de la, Blanca Molins, Marina Mesquida, et al.. (2015). Cytokine profile in active scleritis. Investigative Ophthalmology & Visual Science. 56(7). 3504–3504.
17.
Mesquida, Marina, Blanca Molins, Víctor Llorenç, Maite Sáinz de la Maza, & Alfredo Adán. (2014). Long-Term Effects of Tocilizumab Therapy for Refractory Uveitis-Related Macular Edema. Ophthalmology. 121(12). 2380–2386. 68 indexed citations
18.
Adán, Alfredo. (2004). El papel de la triamcinolona intravítrea en el tratamiento del edema macular diabético. 12(4). 1.
19.
Adán, Alfredo, Manuel González, Elisa Viñuela, Heidrun Vogt, & Guy Smagghe. (1998). Side-effects of azadirachtin, via residual contact, in young larvae of the predator Chrysoperla carnea (Stephens) (Neuroptera, Chrysopidae). 1 indexed citations
20.
Adán, Alfredo, et al.. (1996). [Pathology of the retina in patients with AIDS].. PubMed. 24(136). 1614–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graham R. Wallace Breakdown of academic impact, for papers by Phyllis B. Silver Breakdown of academic impact, for papers by Moncef Khairallah Breakdown of academic impact, for papers by Marc Labétoulle Breakdown of academic impact, for papers by Eiichi Uchio Breakdown of academic impact, for papers by S. D. Cook Breakdown of academic impact, for papers by Jaime Levy Breakdown of academic impact, for papers by Atsuki Fukushima Breakdown of academic impact, for papers by Mathea R. Allansmith Breakdown of academic impact, for papers by Henry D. Perry
Rankless by CCL
2026